TY - JOUR
T1 - Characteristics of Movement-Induced Dose Reduction in Target Volume
T2 - A Comparison Between Photon and Proton Beam Treatment
AU - Yoon, Myonggeun
AU - Shin, Dongho
AU - Kwak, Jungwon
AU - Park, Soah
AU - Lim, Young Kyung
AU - Kim, Dongwook
AU - Park, Sung Yong
AU - Lee, Se Byeong
AU - Shin, Kyung Hwan
AU - Kim, Tae Hyun
AU - Cho, Kwan Ho
N1 - Funding Information:
This work was supported by a research grant from the National Cancer Center, Korea (no. 0810210-1).
Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009/9
Y1 - 2009/9
N2 - We compared the main characteristics of movement-induced dose reduction during photon and proton beam treatment, based on an analysis of dose-volume histograms. To simulate target movement, a target contour was delineated in a scanned phantom and displaced by 3 to 20 mm. Although the dose reductions to the target in the 2 treatment systems were similar for transverse (perpendicular to beam direction) target motion, they were completely different for longitudinal (parallel to beam direction) target motion. While both modalities showed a relationship between the degree of target shift and the reduction in dose coverage, dose reduction showed a strong directional dependence in proton beam treatment. Clinical simulation of target movement for a prostate cancer patient showed that, although coverage and conformity indices for a 6-mm lateral movement of the prostate were reduced by 9% and 16%, respectively, for proton beam treatment, they were reduced by only 1% and 7%, respectively, for photon treatment. This difference was greater for a 15-mm target movement in the lateral direction, which lowered the coverage and conformity indices by 34% and 54%, respectively, for proton beam treatment, but changed little during photon treatment. In addition, we found that the equivalent uniform dose (EUD) and homogeneity index show similar characteristics during target movement. These results suggest that movement-induced dose reduction differs significantly between photon and proton beam treatment. Attention should be paid to the target margin in proton beam treatment due to the distinct characteristics of heavy ion beams.
AB - We compared the main characteristics of movement-induced dose reduction during photon and proton beam treatment, based on an analysis of dose-volume histograms. To simulate target movement, a target contour was delineated in a scanned phantom and displaced by 3 to 20 mm. Although the dose reductions to the target in the 2 treatment systems were similar for transverse (perpendicular to beam direction) target motion, they were completely different for longitudinal (parallel to beam direction) target motion. While both modalities showed a relationship between the degree of target shift and the reduction in dose coverage, dose reduction showed a strong directional dependence in proton beam treatment. Clinical simulation of target movement for a prostate cancer patient showed that, although coverage and conformity indices for a 6-mm lateral movement of the prostate were reduced by 9% and 16%, respectively, for proton beam treatment, they were reduced by only 1% and 7%, respectively, for photon treatment. This difference was greater for a 15-mm target movement in the lateral direction, which lowered the coverage and conformity indices by 34% and 54%, respectively, for proton beam treatment, but changed little during photon treatment. In addition, we found that the equivalent uniform dose (EUD) and homogeneity index show similar characteristics during target movement. These results suggest that movement-induced dose reduction differs significantly between photon and proton beam treatment. Attention should be paid to the target margin in proton beam treatment due to the distinct characteristics of heavy ion beams.
KW - Dose-volume histogram
KW - Equivalent uniform dose
KW - Proton beam treatment
KW - Target movement
UR - http://www.scopus.com/inward/record.url?scp=67651236738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67651236738&partnerID=8YFLogxK
U2 - 10.1016/j.meddos.2008.08.004
DO - 10.1016/j.meddos.2008.08.004
M3 - Article
C2 - 19647628
AN - SCOPUS:67651236738
SN - 0958-3947
VL - 34
SP - 191
EP - 201
JO - Medical Dosimetry
JF - Medical Dosimetry
IS - 3
ER -